579-A Targeting the NANOG-CRY1 axis sensitizes immunotherapy-refractory tumors and enhances efficacy of T cell-based immunotherapy by reinvigorating the anti-tumor immunity cycle

• Tae Woo Kim,
• Min Kyu Son,
• Se Jin Oh

Affiliations

Tae Woo Kim

Korea University College of Medicine, Seoul, Republic of Korea

Min Kyu Son

Korea University College of Medicine, Seoul, Republic of Korea

Se Jin Oh

Korea University College of Medicine, Seoul, Republic of Korea